Skip to content

Alumis Inc. ALMS Unrealized gains (losses) on available-for-sale securities

Unrealized gains (losses) on available-for-sale securities at other companies

AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
-$122K+15.3%

Other financials

Income statement

See full
Revenue$1.7M-90.0%
Operating income-$98.4M+3.1%
Net income-$93.1M+6.0%
EPS (diluted)-$0.74+59.3%

Balance sheet

See full
Cash & equivalents$63.9M-50.3%
Total debt$35.7M+1,881%
Total equity$567.0M+237%
Total assets$671.6M+157%

Cash flow

See full
Operating cash flow-$87.1M-8.4%
CapEx$164.0K+343%
Free cash flow-$87.2M-8.5%

Valuation

See full
Market cap$3.17B+739%

Profitability

See full
Operating margin-5,364%
Net margin-2,825.7%
FCF margin-4,487.4%

Returns & leverage

See full
Return on equity-64.6%
Debt / equity0.1×+0.1×
Current ratio7.5×+3.8×

Where this comes from

Reported directly by Alumis Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax.

The official record: Alumis Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alumis Inc.'s unrealized gains (losses) on available-for-sale securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alumis Inc.'s unrealized gains (losses) on available-for-sale securities?
Alumis Inc. (ALMS) reported unrealized gains (losses) on available-for-sale securities of -$655K in Q1 2026.
How has Alumis Inc.'s unrealized gains (losses) on available-for-sale securities changed year-over-year?
Alumis Inc.'s unrealized gains (losses) on available-for-sale securities decreased by 1264.6% year-over-year, from -$48K to -$655K.
What does unrealized gains (losses) on available-for-sale securities mean?
This captures the unrealized changes in the fair value of available-for-sale investment securities that are excluded from net income and reported in equity. It reflects the market-driven fluctuations in the value of the company's investment portfolio. This metric is essential for understanding the total economic impact of market conditions on the company's capital base beyond standard operating results.